The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib.
 
Constantine Si Lun Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Novartis; Pharmacyclics
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); Janssen-Cilag (Inst)
 
Stephen Opat
Honoraria - Abbvie; AstraZeneca; Gilead Sciences; Janssen; Merck; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Gilead Sciences; Janssen; Merck; Novartis; Roche
Research Funding - Amgen; AstraZeneca; BeiGene; Epizyme; Janssen; Merck; Roche
Travel, Accommodations, Expenses - Roche
 
Paula Marlton
Honoraria - Abbvie; Celgene; Janssen-Cilag; Novartis; Roche
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene; Janssen-Cilag; Novartis; Roche
Travel, Accommodations, Expenses - Roche
 
David Gottlieb
Stock and Other Ownership Interests - Indee P/L
Honoraria - Abbvie; Gilead Sciences; LINK Medical; Merck; Novartis; Pfizer
Research Funding - Haemalogix
 
David Simpson
Employment - Beigene
Stock and Other Ownership Interests - Beigene
Honoraria - Abbvie; Janssen; Roche
Consulting or Advisory Role - Abbvie; Janssen
Research Funding - Abbvie; Acerta Pharma; Amgen; Beigene; Celgene; GlaxoSmithKline; MSD; Pharmacyclics; Roche; Sanofi
Travel, Accommodations, Expenses - Abbvie
 
Gavin Cull
Research Funding - Acerta Pharma; BeiGene; GlycoMimetics
Travel, Accommodations, Expenses - GlycoMimetics
 
David Ritchie
Honoraria - Amgen; Novartis; Pfizer; Takeda
 
Emma Verner
Research Funding - Janssen
 
Javier Munoz
Honoraria - Kyowa Hakko Kirin; Seagen
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Fosun Kite; Genentech; Gilead Sciences; Innovent Biologics; Janssen; Juno Therapeutics; Kite, a Gilead company; Kyowa Hakko Kirin; Pfizer; Pharmacyclics; Seagen
Speakers' Bureau - Abbvie/Genentech; Acrotech Biopharma; AstraZeneca; Bayer; BeiGene; BeiGene; Celgene; Gilead Sciences; Kite, a Gilead company; Kyowa Hakko Kirin; Pharmacyclics/Janssen; Seagen; Verastem
Research Funding - Celgene; Genentech/Abbvie; Incyte; Kite, a Gilead company; Millennium; Pharmacyclics/Janssen; Portola Pharmaceuticals; Seagen
 
Alessandra Tedeschi
Honoraria - Abbvie; AstraZeneca; Janssen
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen
 
Jane Huang
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
 
William Novotny
No Relationships to Disclose
 
Ziwen Tan
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Eric Holmgren
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Siminder K. Atwal
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
John Francis Seymour
Honoraria - Abbvie; Acerta Pharma; Janssen; Roche; Sunesis Pharmaceuticals; Takeda
Consulting or Advisory Role - Abbvie; Acerta Pharma; Janssen; Roche; Sunesis Pharmaceuticals; Takeda
Speakers' Bureau - Abbvie; celgene; Roche
Research Funding - Abbvie; Celgene; Janssen; Roche
Expert Testimony - Roche
Travel, Accommodations, Expenses - Abbvie; Roche
 
Andrew Warwick Roberts
Research Funding - AbbVie (Inst); Amgen (Inst); BeiGene (Inst); Janssen (Inst); Merck (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - Milestone and Royalty payments to Walter and Eliza Hall Institute for venetoclax (Inst); Royalties from venetoclax paid to Walter and Eliza Hall Institute and partly shared with contributors
 
Judith Trotman
Research Funding - Beigene (Inst); celgene (Inst); Janssen-Cilag (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche/Genentech